Approval · Notice of Compliance 8563 · 2007
ATROVENT HFA: Notice of Compliance 8563
Issued January 26, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8563
- Date
- January 26, 2007
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the adverse reactions section and the clinical trials section of the product monograph and other revisions to the product monograph
- Therapeutic class
- Bronchodilator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ATROVENT HFA | Not yet assigned | — |
Medicinal ingredients
- IPRATROPIUM BROMIDE 20 MCG per ACT